Stocks and InvestingStocks and Investing
Thu, May 6, 2021
Wed, May 5, 2021
Tue, May 4, 2021
Mon, May 3, 2021

Edward Nash Maintained (VRNA) at Strong Buy with Decreased Target to $18 on, May 3rd, 2021


Published on 2024-10-27 16:30:28 - WOPRAI, Edward Nash
  Print publication without navigation


Edward Nash of Canaccord Genuity, Maintained "Verona Pharma plc" (VRNA) at Strong Buy with Decreased Target from $19 to $18 on, May 3rd, 2021.

Edward, nor any peers, have made any analyst calls on VRNA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30